国内透析比例逐渐上升 300亿血透市场大扫描

admin

                    

                    

                    
                    
                    <section data-role="outer" label="Powered by gulangu" style="max-width: 100%;color: rgb(51, 51, 51);"><section data-role="paragraph" class="" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section class="" data-tools="gulangu" data-id="88767" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 10px;margin-bottom: 10px;max-width: 100%;box-sizing: border-box;word-wrap: break-word !important;"><section style="padding-bottom: 1.2em;max-width: 100%;box-sizing: border-box;word-wrap: break-word !important;"><section class="" style="margin-top: -0.5em;padding: 10px 2em;max-width: 100%;box-sizing: border-box;word-wrap: break-word !important;"><p style="margin-top: 10px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(89, 89, 89);font-size: 15px;box-sizing: border-box !important;word-wrap: break-word !important;">我国的血透患者数量逐年增加，2016年血液透析患者已经达到了44.7万人。若实际按年透析费用7.5万元计算，<strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(78, 32, 104);box-sizing: border-box !important;word-wrap: break-word !important;">目前我国血透市场规模约335亿</span></strong>。</span></p><p style="margin-top: 10px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(89, 89, 89);font-size: 15px;box-sizing: border-box !important;word-wrap: break-word !important;">而根据CNRDS数据显示，2016年国内的血液透析中心数量为4089家，腹膜透析中心为1100家左右。</span></p><p style="margin-top: 10px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(89, 89, 89);font-size: 15px;box-sizing: border-box !important;word-wrap: break-word !important;">据专家的预测，<strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(78, 32, 104);box-sizing: border-box !important;word-wrap: break-word !important;">中国在透析比例逐渐上升之后，应该需要1万家左右的血液透析中心</span></strong>。</span></p></section><section style="max-width: 100%;box-sizing: border-box;display: inline-block;height: 1em;float: right;line-height: 1;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;display: inline-block;vertical-align: top;width: 4em;border-bottom: 1px solid rgb(204, 164, 227);word-wrap: break-word !important;"></section><span style="margin-top: -0.11em;margin-left: -0.1em;max-width: 100%;box-sizing: border-box;display: inline-block;vertical-align: top;font-size: 80px;color: rgb(78, 32, 104);word-wrap: break-word !important;">”</span></section></section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">随着国家政策的放开，独立血透中心具有广阔的市场空间，现在越来越多社会资本涌入这个细分领域，整体来看，机会多但是挑战也很大。</p><section class="" data-tools="gulangu" data-id="32290" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 5px;margin-bottom: 5px;max-width: 100%;box-sizing: border-box;clear: both;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;border-top: 2.5px solid rgb(204, 164, 227);border-right-color: rgb(204, 164, 227);border-bottom-color: rgb(204, 164, 227);border-left-color: rgb(204, 164, 227);font-size: 1em;text-decoration: inherit;color: rgb(254, 254, 254);word-wrap: break-word !important;"><section style="margin-top: 2px;max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: initial;border-color: rgb(204, 164, 227);overflow: hidden;color: inherit;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;display: inline-block;font-size: 1em;font-family: inherit;text-align: inherit;text-decoration: inherit;color: inherit;border-color: rgb(204, 164, 227);word-wrap: break-word !important;"><section class="" data-bcless="darken" data-brushtype="text" style="padding: 5px 10px;max-width: 100%;display: inline-block;line-height: 1.4em;height: 32px;vertical-align: top;font-family: inherit;font-weight: bold;float: left;color: inherit;border-color: rgb(160, 86, 203);background-color: rgb(204, 164, 227);box-sizing: border-box !important;word-wrap: break-word !important;">政策背景</section><section style="max-width: 100%;display: inline-block;vertical-align: top;width: 0px;height: 0px;border-top: 32px solid rgb(204, 164, 227);border-right: 32px solid transparent;border-top-right-radius: 4px;border-bottom-left-radius: 2px;color: inherit;box-sizing: border-box !important;word-wrap: break-word !important;"></section></section></section></section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">国家卫生计生委2016年底发布的《国家卫生计生委关于印发血液透析中心基本标准和管理规范（试行）的通知》中指出，<span style="max-width: 100%;color: rgb(122, 79, 214);box-sizing: border-box !important;word-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;">独立血透中心“开展血液透析服务”</strong></span>。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2016年底推出的标准和2014年公布的《独立血液透析中心管理规范》相比，<span style="max-width: 100%;color: rgb(122, 79, 214);box-sizing: border-box !important;word-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;">实际上降低了血透中心的准入门槛</strong></span>。过去，必须要求拥有肾内科的二级以上医院才可以建立透析中心，而后来独立的血透中心只需要十公里范围以内签约二级以上综合医院，以及和三甲医院签订保证转诊的绿色通道就可以建立。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">该文件还指出，独立血透中心的发展方向是“通过连锁化、集团化的规模发展，构建规范化、标准化的管理与服务模式”；出于安全考虑，文件<strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(122, 79, 214);box-sizing: border-box !important;word-wrap: break-word !important;">要求独立血透中心与二级医院和三级医院分别建立协作关系</span></strong>。问题在于，公立医院是否愿意将血透中心拱手让人，对于社会力量来说无疑是一个挑战。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;"><img class="" data-ratio="0.7870090634441088" src="http://mmbiz.qpic.cn/mmbiz_jpg/uzCUFHnl8TpSTGtMJ5jLXRKI5MrXvYiavh4LGFRXWaKGhUic6ic1BMFJ42JvndcIicPlXWxZYia7fca3V4CK6kmicMYg/640?wx_fmt=jpeg" data-type="jpeg" data-w="662" style="border-width: 0px;border-style: initial;border-color: initial;list-style-type: none;font-family: normal;font-size: 14px;line-height: 24px;text-align: center;background-color: rgb(247, 247, 247);width: 668px;box-sizing: border-box !important;word-wrap: break-word !important;visibility: visible !important;" width="100%"  /></p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2017年2月28日，国家卫生计生委发布《关于修改&lt;医疗机构管理条例实施细则&gt;的决定》（国家卫生计生委令第12号），<span style="max-width: 100%;color: rgb(122, 79, 214);box-sizing: border-box !important;word-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;">确定增加血液透析中心等5类医疗机构类别，并纳入社会投资领域</strong></span>，将血透这一冷门细分领域推向热潮。</p><section class="" data-tools="gulangu" data-id="32290" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 5px;margin-bottom: 5px;max-width: 100%;box-sizing: border-box;clear: both;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;border-top: 2.5px solid rgb(204, 164, 227);border-right-color: rgb(204, 164, 227);border-bottom-color: rgb(204, 164, 227);border-left-color: rgb(204, 164, 227);font-size: 1em;text-decoration: inherit;color: rgb(254, 254, 254);word-wrap: break-word !important;"><section style="margin-top: 2px;max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: initial;border-color: rgb(204, 164, 227);overflow: hidden;color: inherit;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;display: inline-block;font-size: 1em;font-family: inherit;text-align: inherit;text-decoration: inherit;color: inherit;border-color: rgb(204, 164, 227);word-wrap: break-word !important;"><section class="" data-bcless="darken" data-brushtype="text" style="padding: 5px 10px;max-width: 100%;display: inline-block;line-height: 1.4em;height: 32px;vertical-align: top;font-family: inherit;font-weight: bold;float: left;color: inherit;border-color: rgb(160, 86, 203);background-color: rgb(204, 164, 227);box-sizing: border-box !important;word-wrap: break-word !important;">市场空间</section><section style="max-width: 100%;display: inline-block;vertical-align: top;width: 0px;height: 0px;border-top: 32px solid rgb(204, 164, 227);border-right: 32px solid transparent;border-top-right-radius: 4px;border-bottom-left-radius: 2px;color: inherit;box-sizing: border-box !important;word-wrap: break-word !important;"></section></section></section></section></section></section><p style="margin-top: 20px;margin-bottom: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">由于血透治疗费用较高，能否实现医保报销是影响患者治疗意愿的一大因素。根据推算，目前我国ESRD患者人数约有200万，每年约有30万患者接受血透治疗，平均透析治疗率不足20%，低于全球平均水平37%，更是远低于欧美等国家90%的透析治疗率，发展空间清晰可见。</p><section class="" data-tools="gulangu" data-id="3126" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 0.5em;margin-bottom: 0.5em;max-width: 100%;box-sizing: border-box;border-width: initial;border-style: none;border-color: rgb(204, 164, 227);word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;width: 40px;height: 40px;float: right;color: inherit;background-color: rgb(254, 254, 254);word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;width: 1px;box-shadow: rgb(103, 103, 103) -1px 1px 2px 0px;color: inherit;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;border-width: 20px;border-style: solid;border-color: transparent transparent rgb(153, 153, 153) rgb(153, 153, 153);color: inherit;word-wrap: break-word !important;"></section><section style="margin-top: -38px;margin-left: 1px;max-width: 100%;box-sizing: border-box;border-width: 18px;border-style: solid;border-color: transparent transparent rgb(254, 254, 254) rgb(254, 254, 254);color: inherit;word-wrap: break-word !important;"></section></section></section><section style="padding: 5px 15px;max-width: 100%;box-sizing: border-box;border-width: 1px;border-style: solid;border-color: rgb(204, 204, 204);color: inherit;word-wrap: break-word !important;"><section data-width="80%" style="margin-left: 8px;max-width: 100%;box-sizing: border-box;width: 508.797px;line-height: 1.5em;border-bottom: 5px solid rgb(204, 164, 227);font-size: 14px;text-align: inherit;text-decoration: inherit;color: rgb(78, 32, 104);border-top-color: rgb(204, 164, 227);border-right-color: rgb(204, 164, 227);border-left-color: rgb(204, 164, 227);word-wrap: break-word !important;"><section style="margin-top: 5px;margin-bottom: 5px;max-width: 100%;box-sizing: border-box;color: inherit;border-color: rgb(204, 164, 227);word-wrap: break-word !important;"><span style="max-width: 100%;border-color: rgb(204, 164, 227);color: inherit;box-sizing: border-box !important;word-wrap: break-word !important;">透析治疗较为昂贵。</span></section></section><section class="" style="margin-top: 0.5em;padding: 8px;max-width: 100%;box-sizing: border-box;font-size: 14px;text-decoration: inherit;color: rgb(78, 32, 104);border-color: rgb(204, 164, 227);word-wrap: break-word !important;"><p style="margin-top: 10px;max-width: 100%;min-height: 1em;line-height: 1.75em;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(89, 89, 89);font-size: 15px;box-sizing: border-box !important;word-wrap: break-word !important;">根据2012年《中国卫生发展绿皮书》的数据，每位血透患者每次透析费用约为500元，<span style="max-width: 100%;color: rgb(128, 100, 162);box-sizing: border-box !important;word-wrap: break-word !important;">每年需接受约156次透析治疗，年透析治疗总费用超7.5万元</span>。</span></p><p style="margin-top: 10px;max-width: 100%;min-height: 1em;line-height: 1.75em;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(89, 89, 89);font-size: 15px;box-sizing: border-box !important;word-wrap: break-word !important;">在CNRDS的统计中，我国的血透患者数量逐年增加，2016年血液透析患者已经达到了44.7万人。<span style="max-width: 100%;color: rgb(128, 100, 162);box-sizing: border-box !important;word-wrap: break-word !important;">若实际按年透析费用7.5万元计算，目前我国血透市场规模约335亿</span>。</span></p><p style="margin-top: 10px;max-width: 100%;min-height: 1em;line-height: 1.75em;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(89, 89, 89);font-size: 15px;box-sizing: border-box !important;word-wrap: break-word !important;">而根据CNRDS数据显示，2016年国内的血液透析中心数量为4089家，腹膜透析中心为1100家左右。据专家的预测，<span style="max-width: 100%;color: rgb(128, 100, 162);box-sizing: border-box !important;word-wrap: break-word !important;">中国在透析比例逐渐上升之后，应该需要1万家左右的血液透析中心</span>。</span></p></section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;">随着我国大病医保进一步扩容，2013年以来，血透治疗的报销比例不低于90%，将为血透市场的发展进一步释放能量。因此，虽然连锁经营的独立血透中心能够凭借规模化发展减少成本、降低费用，但能否加入医保及医保报销比例如何，仍将关系到患者选择。</span><br style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"  /></p></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">而独立血透中心的成本主要由五部分组成：透析机、透析耗材、透析药品、人工服务、建筑成本。其实，<strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(122, 79, 214);box-sizing: border-box !important;word-wrap: break-word !important;">运营独立血透中心利润低、挑战大，但门槛高、稳定性强</span></strong>。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;text-align: center;box-sizing: border-box !important;word-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;">重点地区：</span></strong></p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><img class="" data-ratio="0.8036529680365296" src="http://mmbiz.qpic.cn/mmbiz_jpg/uzCUFHnl8TpSTGtMJ5jLXRKI5MrXvYiav5bOGAQ3vw4ywotx4GcaZ3P54c78kgXfV2GQgnvyicuAdzicw4mzGa9UQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="657" style="border-width: 0px;border-style: initial;border-color: initial;list-style-type: none;font-family: normal;line-height: 24px;text-align: center;background-color: rgb(247, 247, 247);width: 668px;box-sizing: border-box !important;word-wrap: break-word !important;visibility: visible !important;" width="100%"  /></span></strong></p><p style="margin-top: 5px;margin-bottom: 20px;max-width: 100%;min-height: 1em;text-align: center;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;font-size: 12px;color: rgb(136, 136, 136);box-sizing: border-box !important;word-wrap: break-word !important;">全国血透患者数量分布，数据来源CNRDS</span></p><section class="" data-tools="gulangu" data-id="32290" data-color="#cca4e3" data-custom="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 5px;margin-bottom: 5px;max-width: 100%;box-sizing: border-box;clear: both;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;border-top: 2.5px solid rgb(204, 164, 227);border-right-color: rgb(204, 164, 227);border-bottom-color: rgb(204, 164, 227);border-left-color: rgb(204, 164, 227);font-size: 1em;text-decoration: inherit;color: rgb(254, 254, 254);word-wrap: break-word !important;"><section style="margin-top: 2px;max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: initial;border-color: rgb(204, 164, 227);overflow: hidden;color: inherit;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;display: inline-block;font-size: 1em;font-family: inherit;text-align: inherit;text-decoration: inherit;color: inherit;border-color: rgb(204, 164, 227);word-wrap: break-word !important;"><section class="" data-bcless="darken" data-brushtype="text" style="padding: 5px 10px;max-width: 100%;display: inline-block;line-height: 1.4em;height: 32px;vertical-align: top;font-family: inherit;font-weight: bold;float: left;color: inherit;border-color: rgb(160, 86, 203);background-color: rgb(204, 164, 227);box-sizing: border-box !important;word-wrap: break-word !important;">市场布局情况</section><section style="max-width: 100%;display: inline-block;vertical-align: top;width: 0px;height: 0px;border-top: 32px solid rgb(204, 164, 227);border-right: 32px solid transparent;border-top-right-radius: 4px;border-bottom-left-radius: 2px;color: inherit;box-sizing: border-box !important;word-wrap: break-word !important;"></section></section></section></section></section></section><section class="" data-tools="gulangu" data-id="85597" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section data-width="100%" style="padding: 10px;max-width: 100%;box-sizing: border-box;width: 668px;word-wrap: break-word !important;"><section style="margin-right: auto;margin-bottom: -2px;margin-left: -3px;max-width: 100%;box-sizing: border-box;border-radius: 100%;line-height: 1;text-decoration: inherit;border-color: rgb(204, 164, 227);display: inline-block;height: 8px;width: 8px;color: rgb(78, 32, 104);background-color: rgb(204, 164, 227);word-wrap: break-word !important;"></section><section data-width="100%" style="margin-top: -10px;max-width: 100%;width: 648px;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-style="line-height:1.75em;font-size:14px;" data-width="97%" style="padding: 10px;max-width: 100%;box-sizing: border-box;display: inline-block;border-left: 1px solid rgb(204, 164, 227);border-bottom: 1px solid rgb(204, 164, 227);width: 628.547px;word-wrap: break-word !important;"><p style="max-width: 100%;min-height: 1em;line-height: 1.75em;font-size: 14px;box-sizing: border-box !important;word-wrap: break-word !important;">在国家政策于2016年底放开之前，国内独立血透中心只有沈阳三生制药股份有限公司（下称三生制药）、白求恩基金管理委员会、威高集团有限公司（下称威高集团）等少数几张牌照，尚处于探索阶段。更多来自于国内外的社会力量，选择通过医院共建模式进入血透服务领域。<br style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"  /></p></section><section class="" data-style="line-height:1.75em;font-size:14px;" data-width="97%" style="padding: 10px;max-width: 100%;box-sizing: border-box;display: inline-block;border-right: 1px solid rgb(204, 164, 227);border-top: 1px solid rgb(204, 164, 227);width: 628.547px;word-wrap: break-word !important;"><p style="max-width: 100%;min-height: 1em;line-height: 1.75em;font-size: 14px;box-sizing: border-box !important;word-wrap: break-word !important;">2009年前后，沈阳三生公司（国内EPO生产商）在辽宁省锦州等地建立了“三生肾友之家”，着手建立“连锁基层血液透析中心” 。2010年12月，山东批准了威高公司、白求恩基金管理委员会的试点。在当时政策不明的情况下，三家民营企业通过挂靠等方式开始了第三方血透中心的试点。</p></section><section style="margin-bottom: -14px;margin-left: -4px;max-width: 100%;box-sizing: border-box;vertical-align: text-bottom;border-radius: 100%;line-height: 1;text-decoration: inherit;border-color: rgb(204, 164, 227);display: inline-block;height: 8px;width: 8px;color: rgb(78, 32, 104);background-color: rgb(204, 164, 227);word-wrap: break-word !important;"></section></section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">透析服务从2012年才纳入大病医保，目前各地报销比例大约在70%-85%，<strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(122, 79, 214);box-sizing: border-box !important;word-wrap: break-word !important;">且此前政策不允许私营资本单独设立</span></strong>，因此民营/外资透析中心发展缓慢，全国4000多家透析中心，90%在公立医院中。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2017年2月28日，国家卫生计生委发布《关于修改&lt;医疗机构管理条例实施细则&gt;的决定》（国家卫生计生委令第12号），<span style="max-width: 100%;color: rgb(122, 79, 214);box-sizing: border-box !important;word-wrap: break-word !important;">确定增加血液透析中心等5类医疗机构类别，并纳入社会投资领域</span>，将血透这一冷门细分领域推向热潮。</p><section class="" data-tools="gulangu" data-id="47131" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section class="" style="margin: 10px 3px;max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><section data-width="100%" style="max-width: 100%;box-sizing: border-box;line-height: 10px;color: inherit;border-width: 1px;border-style: solid;border-color: rgb(204, 164, 227);display: inline-block;width: 662px;word-wrap: break-word !important;"><section style="margin-top: -8px;margin-bottom: -8px;max-width: 100%;box-sizing: border-box;color: inherit;height: 8px;word-wrap: break-word !important;"><section style="margin-right: auto;margin-bottom: -2px;margin-left: -4px;max-width: 100%;box-sizing: border-box;border-radius: 100%;line-height: 1;text-decoration: inherit;border-color: rgb(204, 164, 227);display: inline-block;height: 8px;width: 8px;color: rgb(78, 32, 104);background-color: rgb(204, 164, 227);word-wrap: break-word !important;"></section><section style="margin: 4px -4px -4px;max-width: 100%;box-sizing: border-box;border-radius: 100%;line-height: 1;text-decoration: inherit;border-color: rgb(204, 164, 227);display: inline-block;height: 8px;width: 8px;color: rgb(78, 32, 104);float: right;background-color: rgb(204, 164, 227);word-wrap: break-word !important;"></section><section class="" data-style="text-indent: 2em;" style="margin: 10px;padding: 5px;max-width: 100%;box-sizing: border-box;word-wrap: break-word !important;line-height: 2em;color: rgb(62, 62, 62);font-size: 14px;"><p style="max-width: 100%;min-height: 1em;text-indent: 2em;box-sizing: border-box !important;word-wrap: break-word !important;">目前血液透析产业主要分布在广东、山东、福建等地；活跃的跨国企业主要有费森尤斯、百特、DaVita，日本的日机装、东丽、尼普洛等。</p><p style="max-width: 100%;min-height: 1em;text-indent: 2em;box-sizing: border-box !important;word-wrap: break-word !important;">国内独立血透中心主要有白求恩、威高、中信几家投建。费森尤斯采用全产业链覆盖模式，依托自身在器械端的优势，收购医院、建立透析服务点。威高做法相似，建立肾脏病医院和血液透析中心相结合模式；中信则靠收购医院，进而投资独立血透中心。</p></section><section style="margin-right: auto;margin-bottom: -2px;margin-left: -4px;max-width: 100%;box-sizing: border-box;border-radius: 100%;line-height: 1;text-decoration: inherit;border-color: rgb(204, 164, 227);display: inline-block;height: 8px;width: 8px;color: rgb(78, 32, 104);background-color: rgb(204, 164, 227);word-wrap: break-word !important;"></section><section style="margin: 6px -4px -4px;max-width: 100%;box-sizing: border-box;border-radius: 100%;line-height: 1;text-decoration: inherit;border-color: rgb(204, 164, 227);display: inline-block;height: 8px;width: 8px;color: rgb(78, 32, 104);float: right;background-color: rgb(204, 164, 227);word-wrap: break-word !important;"></section></section></section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">现在具体来看一下资本在国内独立血透中心布局的情况。</p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">1</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">三生制药</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">三生制药是国内最早进入独立血透中心的企业，目前有10多家独立血透中心。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2009年11月23日，我国首个基层连锁血液透析中心——“三生肾友之家”在辽宁省锦州市投入使用。查阅新闻，还能看到当年图片。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;text-align: center;box-sizing: border-box !important;word-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><img class="" data-ratio="0.38109756097560976" data-type="jpeg" data-w="656" width="100%" src="http://mmbiz.qpic.cn/mmbiz_jpg/uzCUFHnl8TpSTGtMJ5jLXRKI5MrXvYiavzmDbTjcoVGkb0rtutt661YW3gWyJ00kibN4cOibOLH6KAZa8qnkWQfvg/640?wx_fmt=jpeg" style="background-color: rgb(238, 237, 235);border-width: 1px;border-style: solid;border-color: rgb(238, 237, 235);background-size: 22px;background-position: center center;background-repeat: no-repeat;height: 254.573px !important;box-sizing: border-box !important;word-wrap: break-word !important;width: 668px !important;"  /></strong></p><p style="margin-top: 5px;max-width: 100%;min-height: 1em;text-align: center;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(136, 136, 136);font-size: 12px;box-sizing: border-box !important;word-wrap: break-word !important;">来源：“三生肾友之家”博客</span></p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">2</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">威高集团</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2011年起，威高集团承接在山东省开展独立血液透析中心试点的任务。据了解，目前公司的独立血液透析中心超过10家。2017年，山东威高投入1000万元在泉州设置丰泽威高血液透析中心，设立30个血透单元，设置诊疗科目包括内科（肾病学专业）和医学检验科。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">三生制药与威高集团同处产业链上游，主营业务是医疗器械、耗材和药品。独立血透中心目前只是其业务线的一个小分支。</p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">3</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">达康医疗的独立血透中心已经形成了一定的规模</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">目前，达康医疗拥有国内最多的独立血透中心。截至2016年12月，达康医疗借助国内投资力量，在江西、山东、河北、山西、广东等14个省市，建成并运营独立血液透析中心100余家。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">达康医疗的每家血液透析服务中心的投资额度在300万-400万不等。对于资金需求，达康并不担心。因为除了本身项目现金流状况良好，在其背后还有几家投资机构的支持。除了基石资本、鼎晖投资、开物投资，还有一家具有国企背景的投资机构——崇山资本都成了达康医疗的股东。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">达康医疗的公开数据显示，其各血透中心的透析设备使用率超过80%，患者数量和收益均呈快速增长态势。据了解，达康医疗目前正在面向全国诚邀合作伙伴，共同开设血透中心。</p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">4</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">中国医药投资510万元成立血透中心</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2017年12月15日，中国医药发布公告，中国医药旗下控股公司广东通用与广州亿德医疗投资管理有限公司签署《关于新设公司之股权合作协议》，双方拟共同出资设立广东通用血液透析中心有限公司。新公司注册资本 1,000 万元，其中，广东通用以货币形式出资 510 万元，占新公司 51%股权；亿德医疗以货币形式出资 490 万元，占新公司 49%股权。</p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">5</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">维力医疗出资1500万元，设立两家血透中心</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2017年10月11日，维力医疗发布公告称，其控股孙公司广东韦士泰血液透析所有限公司以自有资金出资500万元，设立全资子公司广州韦士泰富华血液透析中心有限公司，用于建立血液透析中心及开展血液透析业务。同时，其控股孙公司贵州韦士泰医院投资管理有限公司日以自有资金出资1000万元，设立全资子公司遵义韦士泰血液透析中心有限公司用于建立血液透析中心及开展血液透析业务。公告显示，目前两家血透中心已完成工商登记手续，并取得了广州市和遵义市相关部门核发的营业执照。</p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">6</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">常山药业设立两家血液透析中心</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2016年，常山药业的全资子公司久康医疗投资管理河北有限公司，便利用自有资金500万元，出资设立石家庄新华常山药业血液透析中心。2017年6月22日，常山药业发布公告称，其与涿州华信中医医院签订了《关于在涿州市设立血液透析中心的协议》，拟双方进行资源对接与互助，在涿州市设立血液透析中心，共同提供医疗服务。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">根据合作协议可知，常山药业和涿州华信中医医院的合作期限为10年，拟建的血液透析中心前期总投资定为750万元，后期发展可逐步增加透析设备，扩大投资规模。在投资情况方面，常山药业以进口的透析设备、耗材、水处理设备等和技术管理的形式投资，预计约为450万元，占全部股份的60%；涿州华信中医医院以透析中心提供的场所、装修、购置办公用品、手续办理等的形式投资，预计约为300万元，占全部股份的40%。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">在合作分工方面，常山药业拟投入20台进口血液透析机，同时负责透析的专业技术指导、人员培训、设备的维护保养，肾病专科门诊及血液透析中心的全面经营与管理。而涿州华信中医医院将参与血透中心的经营与管理，负责经营场所设施、办公用品提供、按照公司的专业技术要求进行装修，并负责外联协调工作。</p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">7</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">新华医疗集团建30家血液透析中心</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2015年7月4日，新华医疗集团与山西龙城医院（山西省慈善医院）正式签署合作协议，双方将在山西省范围内投资兴建并托管至少30家独立血液透析中心，预计投入血液透析机1200台以上。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">经山西省卫生计生委积极引进，新华医疗集团将社会资本投入山西省医疗服务领域，拟与非营利性社会办医机构——山西龙城医院合作，在全省范围内投资兴建并托管至少30家独立血液透析中心，预计投入血液透析机1200台以上。同时，要兴建不少于3家二级以上肾病专科医院。该项目至少可以解决约6000名慢性肾病患者就近透析及后续治疗。</p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">8</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">费森尤斯抢占国内市场</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">随着政策的放开和医疗支付能力的提升，国际血透企业正抢占国内市场。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2017年8月8日，福建省卫生计生委发函宣布同意设置“福州费森尤斯血液透析中心”。该中心由费森尤斯医药香港有限公司投资人民币2000万元建立，共设置32个血透单元。另从福建省商务厅获悉，费森尤斯在泉州市已有2个项目在建。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">2017年4月，费森尤斯旗下关联公司完成对昆明五华保健医院的股权收购，拥有该医院70%股权，迈出费森尤斯在云南投资的第一步。2017年8月20日，费森尤斯医疗投资（中国）有限公司与云南省政府签署“进云南暨血透服务项目合作备忘录”。未来3-5年，费森医疗计划在云南再建立两家肾病医院及20-25家透析中心。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">截至2016年底，费森尤斯在全球45个国家共布局3624家透析诊所。</p><section class="" data-tools="gulangu" data-id="87856" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 1em;margin-bottom: 1em;max-width: 100%;font-size: 14px;line-height: 20px;clear: both;box-sizing: border-box !important;word-wrap: break-word !important;"><section class="" data-original-title="" title="" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(78, 32, 104);font-weight: bold;border-top-left-radius: 3px;border-bottom-left-radius: 3px;background-color: rgb(204, 164, 227);word-wrap: break-word !important;">9</section><section class="" data-bgless="lighten" data-brushtype="text" data-bglessp="20%" style="padding: 5px 10px;max-width: 100%;box-sizing: border-box;display: inline-block;color: rgb(148, 32, 206);font-weight: bold;border-top-right-radius: 3px;border-bottom-right-radius: 3px;background-color: rgb(248, 242, 251);word-wrap: break-word !important;">DaVita</section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">DaVita通过和中国医院进行合作共建，拥有3家透析中心，比如和上海杨浦安图医院、山东舜井肾病医院进行合作建立的透析中心。</p><section class="" data-tools="gulangu" data-id="32290" data-color="#cca4e3" style="max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="margin-top: 5px;margin-bottom: 5px;max-width: 100%;box-sizing: border-box;clear: both;border-width: 0px;border-style: none;border-color: initial;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;border-top: 2.5px solid rgb(204, 164, 227);border-right-color: rgb(204, 164, 227);border-bottom-color: rgb(204, 164, 227);border-left-color: rgb(204, 164, 227);font-size: 1em;text-decoration: inherit;color: rgb(254, 254, 254);word-wrap: break-word !important;"><section style="margin-top: 2px;max-width: 100%;box-sizing: border-box;border-width: 0px;border-style: initial;border-color: rgb(204, 164, 227);overflow: hidden;color: inherit;word-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box;display: inline-block;font-size: 1em;font-family: inherit;text-align: inherit;text-decoration: inherit;color: inherit;border-color: rgb(204, 164, 227);word-wrap: break-word !important;"><section class="" data-bcless="darken" data-brushtype="text" style="padding: 5px 10px;max-width: 100%;display: inline-block;line-height: 1.4em;height: 32px;vertical-align: top;font-family: inherit;font-weight: bold;float: left;color: inherit;border-color: rgb(160, 86, 203);background-color: rgb(204, 164, 227);box-sizing: border-box !important;word-wrap: break-word !important;">小结</section><section style="max-width: 100%;display: inline-block;vertical-align: top;width: 0px;height: 0px;border-top: 32px solid rgb(204, 164, 227);border-right: 32px solid transparent;border-top-right-radius: 4px;border-bottom-left-radius: 2px;color: inherit;box-sizing: border-box !important;word-wrap: break-word !important;"></section></section></section></section></section></section><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">从资本在血透中心的布局来看，血透产业链上游的公司建立了一些独立血透中心，但也只是其业务线的一个小分支，一些上市公司近两三年也进行了一些尝试，但进展缓慢，都没有形成规模效应。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">血透行业在发达国家是排名第二位的医疗细分服务市场，而现在在我国市场几乎处于起步阶段。一直以来，独立血透中心发展比较缓慢，除了资质上的问题之外，还有医生资源的短缺。血透中心在场地、医生、护士等方面有严格的管理有求，这些培育需要一个较长的周期。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">我国之前的大多数民营血透中心采用和医院合作的模式，不仅可以解决患者资源，也可以提高品牌认可。但是未来要想往继续发展壮大，实现社区化和基层化，独立的血透中心就会大量出现。</p><p style="margin-top: 20px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;word-wrap: break-word !important;">市场空间看起来很大，但是目前，独立的血透中心还没有找到合适的商业模式，想盈利并不容易。</p></section></section><p style="max-width: 100%;min-height: 1em;color: rgb(51, 51, 51);"><br style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"  /></p><p style="max-width: 100%;min-height: 1em;color: rgb(51, 51, 51);">来源：医药并购圈整理自健康界、动脉网、亿欧网</p><hr  /><section class="" style="white-space: normal;"><section><p><img class="" data-copyright="0" data-ratio="0.6100178890876565" data-s="300,640" src="http://mmbiz.qpic.cn/mmbiz_png/A1DicCH9Vl6MK5Q8sxibcIbgTPECicmaSpkdc8Z9sZ08Rp4HCzAicktdjPgic7Q7trLRwDf6Z3zz8icJhxWHoCn4iaN0w/640?wx_fmt=png" data-type="png" data-w="559"  /></p></section></section><hr style="white-space: normal;max-width: 100%;color: rgb(51, 51, 51);"  /><p style="margin-top: 10px;white-space: normal;max-width: 100%;min-height: 1em;text-align: center;"><strong style="max-width: 100%;font-size: 14px;line-height: 21px;color: rgb(255, 255, 255);font-family: arial, helvetica, sans-serif;box-sizing: border-box !important;word-wrap: break-word !important;"><span class="" style="margin-right: 8px;padding: 4px 10px;max-width: 100%;border-radius: 5px;background-color: rgb(191, 0, 0);box-sizing: border-box !important;word-wrap: break-word !important;"></span></strong><br data-filtered="filtered" style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"  /></p><p style="white-space: normal;max-width: 100%;min-height: 1em;text-align: center;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;line-height: 2em;color: rgb(255, 0, 0);box-sizing: border-box !important;word-wrap: break-word !important;">ID: </span></strong></p><p style="white-space: normal;max-width: 100%;min-height: 1em;text-align: center;"><span style="max-width: 100%;font-size: 14px;box-sizing: border-box !important;word-wrap: break-word !important;">最具人气的医疗器械维修新媒体平台</span></p><p style="white-space: normal;max-width: 100%;min-height: 1em;text-align: center;"><span style="max-width: 100%;font-size: 14px;box-sizing: border-box !important;word-wrap: break-word !important;">医疗器械维修人自己的交流平台</span></p><p style="white-space: normal;max-width: 100%;min-height: 1em;text-align: center;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(127, 127, 127);font-size: 11px;box-sizing: border-box !important;word-wrap: break-word !important;">加群主微信&nbsp;</span></strong><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(149, 55, 52);font-size: 11px;box-sizing: border-box !important;word-wrap: break-word !important;">shanying916</span></strong><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(127, 127, 127);box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;font-size: 11px;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(149, 55, 52);box-sizing: border-box !important;word-wrap: break-word !important;"></span>&nbsp;</span><span style="max-width: 100%;font-size: 12px;box-sizing: border-box !important;word-wrap: break-word !important;">与更多行业从业人员互动交流</span></span></strong><strong style="max-width: 100%;line-height: 1.75em;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(127, 127, 127);font-size: 12px;box-sizing: border-box !important;word-wrap: break-word !important;"></span></strong></p><p style="white-space: normal;max-width: 100%;min-height: 1em;text-align: center;"><strong style="max-width: 100%;box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(127, 127, 127);box-sizing: border-box !important;word-wrap: break-word !important;"><span style="max-width: 100%;font-size: 12px;box-sizing: border-box !important;word-wrap: break-word !important;"><img class="" data-ratio="1.0136054421768708" data-s="300,640" src="http://mmbiz.qpic.cn/mmbiz/A1DicCH9Vl6MoypciaNOibiaxmVLk8eA6ibKL14uWjKsZwrWboQYKTfXqPicXycwL1icfia1pAG0VzlTX3MRR4FPV0ZtZA/640?" data-type="jpeg" data-w="147" width="auto" style="box-sizing: border-box !important;word-wrap: break-word !important;visibility: visible !important;width: auto !important;"  /></span></span></strong></p>